文献速递甲状腺与颈部外科

三发性甲状旁腺功能亢进:手术转诊为何延迟

Tertiary Hyperparathyroidism: Why the Delay?
PubMed 文献 · Ann Surg · 2021-01-01

该回顾性研究纳入38例因三发性甲状旁腺功能亢进(THPT)行甲状旁腺切除术的患者,分析手术转诊延迟的原因及其对移植肾功能的影响。结果显示,中位转诊等待时间为320天,超过50%的转诊原因与西那卡塞使用困难(费用、钙控制不佳、依从性差)有关;早期转诊(<278天)患者肌酐改善优于晚期转诊(27.6% vs -5%,P=0.007)。

要点

  • THPT患者从诊断到转诊至内分泌外科的中位时间为320天,存在明显延迟。
  • 超过50%的转诊延迟与西那卡塞使用困难(费用、钙控制不佳、依从性差)相关。
  • 早期转诊(<278天)与血清肌酐改善相关,提示应尽早转诊。

核心结论

  • THPT患者平均等待约一年才转诊至内分泌外科行根治性甲状旁腺切除术,早期转诊与血清肌酐改善相关。

研究设计与样本

  • 单中心回顾性研究,纳入2016年5月至2018年6月因THPT行甲状旁腺切除术的患者38例,平均年龄53±2岁,66%为男性。

主要发现

  • 术前平均血钙10.8±0.1 mg/dL,平均甲状旁腺激素328±48 pg/mL。
  • 肾移植后诊断THPT的中位时间为15天(范围1-4892天),转诊行甲状旁腺切除术的中位时间为320天(范围16-6281天)。
  • 超过50%的患者转诊至内分泌外科的原因为西那卡塞使用困难,包括费用、钙控制不佳、依从性差或耐受性差。
  • 早期转诊(<278天,n=19)与晚期转诊(>278天,n=19)相比,早期转诊组肌酐改善(27.6% vs -5%,P=0.007)。

临床怎么用

  • 对肾移植后出现持续性高钙血症或甲状旁腺激素升高的患者,应警惕THPT并尽早评估手术指征。
  • 当西那卡塞使用存在费用、疗效或依从性问题时,应考虑及时转诊至内分泌外科。
  • 早期转诊可能有助于保护移植肾功能,避免延迟带来的肌酐恶化。

局限性

  • 本研究为单中心回顾性设计,样本量有限(n=38),可能存在选择偏倚。
  • 早期与晚期转诊的分组截断值(278天)基于本研究数据,外推需谨慎。
  • 未报告多变量分析调整混杂因素后的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the reason for delay of surgical referral in tertiary hyperparathyroidism (THPT) and its impact on renal allograft function. BACKGROUND: Persistent hyperparathyroidism after renal transplant has been shown to negatively impact allograft function, yet referral for definitive treatment of THPT is often delayed. METHODS: A retrospective review was performed of patients undergoing parathyroidectomy for THPT (n = 38) at a single institution from May 2016 to June 2018. The first elevated serum calcium after transplant and time to referral for parathyroid surgery were recorded. Baseline creatinine post-transplant and the most recent creatinine level were used to assess allograft function. RESULTS: Thirty-eight patients were included, with mean age 53 ± 2 years and 66% male. Mean preoperative calcium and parathyroid hormone were 10.8 ± 0.1 mg/dL and 328 ± 48 pg/mL, respectively. THPT after renal transplant was diagnosed at a median of 15 days (range of 1-4892 days). Median time to parathyroidectomy referral was 320 days (range 16-6281 days). In over 50% of patients, the cited reason for referral to an endocrine surgeon was difficulty with cinacalcet - either cost, poor calcium control, and poor compliance or tolerance. In comparing renal function between patients referred early (<278 days, n = 19) versus later (>278 days, n = 19) for parathyroidectomy, those referred early had an improvement in creatinine (27.6% vs -5%, P = 0.007). CONCLUSIONS: Patients with THPT wait approximately a year, on average, before referral to an endocrine surgeon for curative parathyroidectomy; earlier referral was associated with improvement in serum creatinine.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Dream S, Chen H, Lindeman B, et al. Tertiary Hyperparathyroidism: Why the Delay? Ann Surg. 2021. PMID: 32541226. doi:10.1097/SLA.0000000000004069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。